Egln3 - egl-9 family hypoxia-inducible factor 3 Gene
Also Known as PHD3; PHD-3; SM-20
Species: Rattus norvegicus
Summary
Predicted to enable ferrous iron binding activity and peptidyl-proline 4-dioxygenase activity. Involved in regulation of cell population proliferation. Predicted to be located in cytosol. Predicted to be active in cytoplasm and nucleus. Biomarker of acute kidney failure and myocardial infarction. Human ortholog(s) of this gene implicated in renal cell carcinoma. Orthologous to human EGLN3 (egl-9 family hypoxia inducible factor 3). [provided by Alliance of Genome Resources, Apr 2022]
Egln3 Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_019371.2 | NP_062244.2 | prolyl hydroxylase EGLN3 |
| Molecular Function GO Annotation | Evidence | References | Source |
|---|---|---|---|
| enables protein binding |
IPI
IPI: Inferred from physical interaction
|
20849813 | RGD |
| Biological Process GO Annotation | Evidence | References | Source |
|---|---|---|---|
| involved in regulation of cell population proliferation |
IMP
IMP: Inferred from mutant phenotype
|
12379765 | RGD |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
prolyl hydroxylase EGLN3 |
|
|